Company profile: Artesyn Biosolutions
1.1 - Company Overview
Company description
- Provider of single-use valves, components, and systems for the biopharmaceutical industry, designed and manufactured to support increased efficiency in biopharmaceutical production.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Artesyn Biosolutions
Glympse Bio
HQ: United States
Website
- Description: Provider of noninvasive, predictive diagnostic solutions for monitoring multiple human diseases, using precisely engineered diagnostic agents that interrogate the body for disease states and carry the message to the urine for analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Glympse Bio company profile →
MILabs
HQ: The Netherlands
Website
- Description: Provider of high-end molecular imaging solutions for biomedical research, including systems for quantitative 3D functional imaging of SPECT (U-SPECT) and PET (U-PET) tracers, an integrated PET/SPECT platform for simultaneous high-resolution imaging (VECTor), and automated quantitative 3D autoradiography of tissue samples with multiple isotopes (EXIRAD-3D).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MILabs company profile →
ChromoTek
HQ: Germany
Website
- Description: Provider of immunologic research and detection reagents and tools for proteomics and cell biology, offering Nanobody-based Nano-Traps for immunoprecipitation; Chromobodies for real-time, live-cell imaging; Nano-Secondary reagents for higher-resolution imaging with minimal label displacement; Nano-Boosters & Nano-Labels for microscopy; Nano-Caps for one-step protein purification; and Nano-CaptureLigands for site-directed antibody immobilization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ChromoTek company profile →
PrognomiQ
HQ: United States
Website
- Description: Provider of multi-omics liquid biopsy and proteomic profiling for early disease detection. Offers a platform integrating proteomics, genomics, and metabolomics for early-stage cancers such as lung and pancreatic, large-scale plasma proteomics for biomarker discovery, glycoproteome detection across cancer cohorts, and a multi-omics product pipeline for early detection and treatment of cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PrognomiQ company profile →
Carterra
HQ: United States
Website
- Description: Provider of biotechnology solutions for micro-array deposition technologies, delivering instruments and services that enable multiplexing on planar array surfaces. Offerings include LSA and LSAXT for monoclonal antibody characterization (kinetics, epitope binning), Continuous Flow Microspotter (CFM), sensor chips, kinetics and epitope software, and AI/ML in silico tools for drug discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Carterra company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Artesyn Biosolutions
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Artesyn Biosolutions
2.2 - Growth funds investing in similar companies to Artesyn Biosolutions
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Artesyn Biosolutions
4.2 - Public trading comparable groups for Artesyn Biosolutions
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →